Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of Carbetocin Infusion vs Bolus in Elective Caesarean
NCT02636816Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2016
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by University of British Columbia. Primary endpoint: Percent change in cardiac output parameters at 10 minutes. Started Mar 2016; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02636816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636816.